Cargando…

Modulation of Angiogenic and Inflammatory Response in Glioblastoma by Hypoxia

Glioblastoma are rapidly proliferating brain tumors in which hypoxia is readily recognizable, as indicated by focal or extensive necrosis and vascular proliferation, two independent diagnostic criteria for glioblastoma. Gene expression profiling of glioblastoma revealed a gene expression signature a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murat, Anastasia, Migliavacca, Eugenia, Hussain, S. Farzana, Heimberger, Amy B., Desbaillets, Isabelle, Hamou, Marie-France, Rüegg, Curzio, Stupp, Roger, Delorenzi, Mauro, Hegi, Monika E.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694268/ https://www.ncbi.nlm.nih.gov/pubmed/19536297 http://dx.doi.org/10.1371/journal.pone.0005947

Ejemplares similares

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
por: Hau, Peter, et al.
Publicado: (2007)

Upregulation of Interleukin 8 by Oxygen-deprived Cells in Glioblastoma Suggests a Role in Leukocyte Activation, Chemotaxis, and Angiogenesis
por: Desbaillets, Isabelle, et al.
Publicado: (1997)

Are Integrins Still Practicable Targets for Anti-Cancer Therapy?
por: Alday-Parejo, Begoña, et al.
Publicado: (2019)

Radiotherapy Suppresses Angiogenesis in Mice through TGF-βRI/ALK5-Dependent Inhibition of Endothelial Cell Sprouting
por: Imaizumi, Natsuko, et al.
Publicado: (2010)

BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma
por: Gusyatiner, Olga, et al.
Publicado: (2021)

Hyperpolarized (13)C-glucose magnetic resonance highlights reduced aerobic glycolysis in vivo in infiltrative glioblastoma
por: Mishkovsky, Mor, et al.
Publicado: (2021)

Immunotherapy in Glioblastoma: A Clinical Perspective
por: Desbaillets, Nicolas, et al.
Publicado: (2021)

Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma
por: Kurscheid, Sebastian, et al.
Publicado: (2015)

OTME-13. Integration of metabolic and transcriptional signatures of glioblastoma invasion reveals extracellular matrix reorganization and vasculature remodeling
por: Cudalbu, Cristina, et al.
Publicado: (2021)

Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice
por: Cudalbu, Cristina, et al.
Publicado: (2021)

Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison
por: De Meyer, Tim, et al.
Publicado: (2015)

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
por: Bady, Pierre, et al.
Publicado: (2012)

Erratum to: MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
por: Bady, Pierre, et al.
Publicado: (2013)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
por: Weller, Michael, et al.
Publicado: (2016)

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
por: Lan, Qiang, et al.
Publicado: (2018)

DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients
por: Bady, Pierre, et al.
Publicado: (2022)

The Crosstalk between FAK and Wnt Signaling Pathways in Cancer and Its Therapeutic Implication
por: Wörthmüller, Janine, et al.
Publicado: (2020)

MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions
por: Wörthmüller, Janine, et al.
Publicado: (2021)

Standards of care and novel approaches in the management of glioblastoma multiforme
por: Hottinger, Andreas F., et al.
Publicado: (2014)

Membrane-Interacting DNA Nanotubes Induce Cancer Cell Death
por: Kocabey, Samet, et al.
Publicado: (2021)

Myocardial Hypertrophy Overrides the Angiogenic Response to Hypoxia
por: Choi, Yeong-Hoon, et al.
Publicado: (2008)

Hypoxia-Inducible Factor as an Angiogenic Master Switch
por: Hashimoto, Takuya, et al.
Publicado: (2015)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

Ubiquitin Specific Peptidase 15 (USP15) suppresses glioblastoma cell growth via stabilization of HECTD1 E3 ligase attenuating WNT pathway activity
por: Oikonomaki, Maria, et al.
Publicado: (2017)

Characterization and In Vivo Validation of a Three-Dimensional Multi-Cellular Culture Model to Study Heterotypic Interactions in Colorectal Cancer Cell Growth, Invasion and Metastasis
por: Cattin, Sarah, et al.
Publicado: (2018)

Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
por: Lorusso, Girieca, et al.
Publicado: (2020)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts
por: McCord, Matthew, et al.
Publicado: (2022)

Hypoxia and glioblastoma therapy
por: Yang, Chunzhang, et al.
Publicado: (2015)

Hypoxia: The Cornerstone of Glioblastoma
por: Domènech, Marta, et al.
Publicado: (2021)

The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
por: Alghisi, Gian Carlo, et al.
Publicado: (2009)

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
por: Verhoeff, Joost JC, et al.
Publicado: (2009)

Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
por: Onishi, Manabu, et al.
Publicado: (2013)

Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
por: Conroy, Siobhan, et al.
Publicado: (2016)

Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
por: Jeon, Hanwool, et al.
Publicado: (2023)

Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
por: Zhang, Ashley B., et al.
Publicado: (2023)

The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
por: Sforna, Luigi, et al.
Publicado: (2015)

Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy
por: Stalin, Jimmy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kf5ju8p7g6runu7ggj95nq98s6